BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.94−0.04 (-2.02%)
Close on Nov 17, 2026Market cap $155.54MP/E –Yield –
BridgeBio Oncology Therapeutics cash
Cash and short-term investments held at the end of each period.
BridgeBio Oncology Therapeutics's cash was $344.10M at Jun 30, 2026. For fiscal 2025 it was $425.50M, up 173.2% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $425.50M | +173.2% |
| FY2024 | Dec 31, 2024 | $155.76M | +62205.2% |
| FY2023 | Dec 31, 2023 | $250.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $344.10M | +987.2% |
| Q1 FY2026 | Mar 31, 2026 | $388.90M | +1376.0% |
| Q4 FY2025 | Dec 31, 2025 | $425.50M | +173.2% |
| Q3 FY2025 | Sep 30, 2025 | $468.30M | +2194.5% |
| Q2 FY2025 | Jun 30, 2025 | $31.65M | +1644.3% |
| Q1 FY2025 | Mar 31, 2025 | $26.35M | +1329.2% |
| Q4 FY2024 | Dec 31, 2024 | $155.76M | +62205.2% |
| Q3 FY2024 | Sep 30, 2024 | $20.41M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.81M | – |
| Q1 FY2024 | Mar 31, 2024 | $1.84M | – |
| Q4 FY2023 | Dec 31, 2023 | $250.00K | – |
See a number that looks wrong?